Alerts will be sent to your verified email
Verify EmailSMSPHARMA
|
SMS Pharmaceuticals
|
IOL Chem & Pharma
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
2.4 % | 1.01 % | 1.93 % |
|
Financials
|
|||
|
5 yr Average ROE
|
9.71 % | 8.9 % | 18.02 % |
|
5yr average Equity Multiplier
|
1.92 | 1.42 | 1.97 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 0.99 | 1.09 |
|
5yr Avg Net Profit Margin
|
7.52 % | 6.28 % | 8.24 % |
|
Price to Book
|
5.02 | 2.33 | 2.27 |
|
P/E
|
45.06 | 30.49 | 18.07 |
|
5yr Avg Cash Conversion Cycle
|
95.74 Days | 37.81 Days | 79.88 Days |
|
Inventory Days
|
117.18 Days | 65.55 Days | 69.48 Days |
|
Days Receivable
|
94.73 Days | 86.45 Days | 111.3 Days |
|
Days Payable
|
94.13 Days | 100.1 Days | 97.75 Days |
|
5yr Average Interest Coverage Ratio
|
4.95 | 15.8 | 9.61 |
|
5yr Avg ROCE
|
12.07 % | 12.63 % | 21.16 % |
|
5yr Avg Operating Profit Margin
|
17.65 % | 10.64 % | 14.01 % |
|
5 yr average Debt to Equity
|
0.54 | 0.04 | 0.46 |
|
5yr CAGR Net Profit
|
2.03 % | -9.63 % | -9.72 % |
|
5yr Average Return on Assets
|
4.9 % | 6.27 % | 9.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.07 % | 57.48 % | 55.03 % |
|
Share Pledged by Promoters
|
17.99 % | 0.0 | 2.47 % |
|
Change in Promoter Holding (3 Yrs)
|
3.78 % | 9.29 % | -4.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.96 % | 0.0 | 6.13 % |
|
SMS Pharmaceuticals
|
IOL Chem & Pharma
|
Aarti Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
Therapeutic Area Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|